News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Conference News AHA 2021 Avoiding AF Triggers Doesn’t Improve Quality of Life: I-STOP-AFib Michael O'Riordan November 14, 2021
News Conference News TCT 2021 PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Conference News ESC 2021 LOOP and STROKESTOP: Impact of AF Screening May Hinge on Arrhythmia Burden Todd Neale August 29, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News HRS 2021 Progestin OCs Triple CV Events in Women With Congenital Long QT Caitlin E. Cox July 30, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear Shelley Wood March 17, 2021
News Daily News Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis Todd Neale March 02, 2021
News Daily News Experts Update Antithrombotic Advice in AF Patients Undergoing PCI Todd Neale February 09, 2021